DEPDC1 and breast carcinoma: In recent years, several reports have also shown that DEPDC1 is aberrantly upregulated in various tumors and is involved in the occurrence and development of HCC (Amisaki et al., 2019; Guo et al., 2019), breast cancer (Zhao et al., 2019), lung cancer, colorectal cancer (Wang et al., 2020), and glioblastoma (Kikuchi et al., 2017).